Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-13-017983
Filing Date
2013-03-27
Accepted
2013-03-27 17:28:39
Documents
9
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v339283_10ka.htm 10-K/A 51135
2 EXHIBIT 31.1 v339283_ex31-1.htm EX-31.1 10162
3 EXHIBIT 32.1 v339283_ex32-1.htm EX-32.1 4115
  Complete submission text file 0001144204-13-017983.txt   2954193

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT innv-20121231.xml EX-101.INS 279296
5 XBRL TAXONOMY EXTENSION SCHEMA innv-20121231.xsd EX-101.SCH 48608
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE innv-20121231_cal.xml EX-101.CAL 20141
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE innv-20121231_def.xml EX-101.DEF 216893
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE innv-20121231_lab.xml EX-101.LAB 296091
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE innv-20121231_pre.xml EX-101.PRE 259778
Mailing Address 80 WEST SIERRA MADRE BLVD., #392 SIERRA MADRE CA 91024
Business Address 80 WEST SIERRA MADRE BLVD., #392 SIERRA MADRE CA 91024 626-227-1630
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52991 | Film No.: 13720897
SIC: 6770 Blank Checks